Sarepta therapeutics inc latest news

Keywords Suggestions

Sarepta therapeutics inc latest news

( Please select at least 2 keywords )

Related websites

Sarepta Therapeutics, Inc. (SRPT) Latest Stock News

  • Get the latest Sarepta Therapeutics, Inc
  • (SRPT) stock news and headlines to help you in your trading and investing decisions.

Finance.yahoo.com   DA: 17 PA: 17 MOZ Rank: 35

News & Press Releases Sarepta Therapeutics

  • Sarepta Therapeutics Opens Genetic Therapies Center of Excellence in Columbus, Ohio
  • Sarepta Therapeutics Announces Initiation of EMBARK, a Global Pivotal Study of SRP-9001, a Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
  • Sarepta Therapeutics Announces Inducement

Sarepta.com   DA: 15 PA: 9 MOZ Rank: 26

Sarepta Therapeutics, Inc. (SRPT) Latest Stock News

  • Get the latest news and real-time alerts from Sarepta Therapeutics, Inc

Seekingalpha.com   DA: 16 PA: 17 MOZ Rank: 36

Sarepta Therapeutics, Inc. (SRPT) Latest Press Releases

  • Get the latest Sarepta Therapeutics, Inc
  • (SRPT) stock news and headlines to help you in your trading and investing decisions.

Finance.yahoo.com   DA: 17 PA: 27 MOZ Rank: 48

Sarepta Therapeutics Biopharmaceutical Company for Rare

Sarepta Therapeutics Announces Preliminary Financial Results for the Third Quarter Ended September 30, 2021 10/12/2021 Sarepta Therapeutics Announces Proposed $500,000,000 Public …

Sarepta.com   DA: 15 PA: 15 MOZ Rank: 35

Why Sarepta Therapeutics Fell 14.7% This Week The Motley

  • Sarepta Therapeutics ( NASDAQ:SRPT), a biotech company that specializes in genetic therapies for rare diseases, dropped 14.7% this week, according to data from S&P Global Market Intelligence

Fool.com   DA: 12 PA: 50 MOZ Rank: 68

SRPT Stock Price Sarepta Therapeutics Inc. Stock Quote

  • SRPT | Complete Sarepta Therapeutics Inc
  • View real-time stock prices and stock quotes for a full financial overview.

Marketwatch.com   DA: 19 PA: 21 MOZ Rank: 47

Why Sarepta Therapeutics Tumbled Today The Motley Fool

  • On the back of two pieces of news released after market hours on Tuesday, Sarepta Therapeutics (NASDAQ:SRPT) stock fell by over 12% today
  • Investors were displeased with a company update about its

Fool.com   DA: 12 PA: 50 MOZ Rank: 70

Sarepta Therapeutics, Inc. SRPT Securities Fraud

  • New York, NY: A securities class action lawsuit has been filed against Sarepta Therapeutics, Inc
  • ("Sarepta" or the "Company") (NASDAQ: SRPT) and certain of its officers
  • The class action, filed in United States District Court, District of Massachusetts, and docketed under 14-cv-10225 is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired …

Bigclassaction.com   DA: 22 PA: 50 MOZ Rank: 81

Sarepta Therapeutics, Inc. SRPT Securities Fraud

  • New York, NY: A securities class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased Sarepta Therapeutics, Inc
  • ("Sarepta" or the "Company") common stock between July 24, 2013 through November 12, 2013
  • The complaint alleges that Sarepta issued a series of multiple statements …

Bigclassaction.com   DA: 22 PA: 50 MOZ Rank: 82

Sarepta Therapeutics, Inc. (SRPT) Stock Price Today, Quote

  • A high-level overview of Sarepta Therapeutics, Inc
  • Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Seekingalpha.com   DA: 16 PA: 12 MOZ Rank: 39

Sarepta Therapeutics, Inc. Common Stock (DE) (SRPT) News

  • Find the latest news headlines from Sarepta Therapeutics, Inc
  • Common Stock (DE) (SRPT) at Nasdaq.com.

Nasdaq.com   DA: 14 PA: 43 MOZ Rank: 69

Buy or Sell Sarepta Therapeutics Inc. (SRPT) Stock Now

  • (NASDAQ:SRPT) went down by -3.53% from its latest closing price compared to the recent 1-year high of $181.83
  • The company’s stock price has collected -11.03% of loss in the last five trading sessions

Newsheater.com   DA: 14 PA: 50 MOZ Rank: 77

Sarepta Therapeutics Inc. (NASDAQ: SRPT) Reports

  • (NASDAQ: SRPT) has announced its preliminary Q3 2021 financial results
  • The company expects net product revenues of $166.9 million relative to net revenue of $121.4 million a year ago
  • Sarepta has $1.6 billion in cash and equivalents

Biopharmajournal.com   DA: 20 PA: 50 MOZ Rank: 84

35,887 Shares in Sarepta Therapeutics, Inc. (NASDAQ:SRPT

  • Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT) in the second quarter, according to the company in its most recent disclosure with the SEC
  • The firm acquired 35,887 shares of the biotechnology company’s stock, valued at approximately $2,790,000
  • A number of other institutional investors have also recently […]

Americanbankingnews.com   DA: 27 PA: 50 MOZ Rank: 92

Sarepta (SRPT) Begins Pivotal Study on DMD Gene Therapy

  • SRPT announced that it has initiated a pivotal study — EMBARK — on its lead gene therapy candidate, SRP-9001, for …

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 80

Sarepta Therapeutics Announces Pricing of $500 Million

  • Sarepta Therapeutics Announces Pricing of $500 Million Public Offering of Common Stock 10/13/21 9:15 PM EDT CAMBRIDGE, Mass., Oct
  • 13, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has priced an underwritten public offering of 6,172,840

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 96

Sarepta Therapeutics to Showcase Data from its Gene Therapy

  • 14, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present at the World Muscle Society

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 89

SAREPTA THERAPEUTICS, INC. : Stock Market News and

  • : Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K) AQ
  • SAREPTA THERAPEUTICS : Credit Suisse Lowers Sarepta Therapeutics' PT to $95 from $100, Updates Model After Secondary Offering, Preliminary Q3 Results; Keeps

Marketscreener.com   DA: 22 PA: 50 MOZ Rank: 91

SRPT Sarepta Therapeutics Inc. Stock Price & News

  • View the latest Sarepta Therapeutics Inc
  • (SRPT) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Wsj.com   DA: 11 PA: 24 MOZ Rank: 55

Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

  • Sarepta Therapeutics Says Co's SRP-9001 Shows Sustained Functional Improvements In Multiple Studies Of Patients With Duchenne
  • Everything you need to know about the latest SPAC news…

Benzinga.com   DA: 16 PA: 50 MOZ Rank: 87

SRPT News Today (Sarepta Therapeutics) MarketBeat

  • (NASDAQ:SRPT) Given Average Recommendation of "Buy" by Analysts
  • americanbankingnews.com - September 19 at 8:36 AM
  • Even after rising 6.4% this past week, Sarepta Therapeutics (NASDAQ:SRPT) shareholders are still down 44% over the past three years
  • finance.yahoo.com - September 17 at 1:14 PM.

Marketbeat.com   DA: 18 PA: 25 MOZ Rank: 65

Sarepta Therapeutics opens Columbus R&D center for gene

Sarepta Therapeutics has concentrated its main research and development operation at the Genetic Therapies Center of Excellence in Columbus, three …

Bizjournals.com   DA: 19 PA: 50 MOZ Rank: 92

Sarepta Therapeutics Inc. (SRPT): Skating on Thin Ice

  • (NASDAQ:SRPT) went up by 4.70% from its latest closing price compared to the recent 1-year high of $181.83
  • The company’s stock price has collected 7.38% of gains in the last five trading sessions
  • Press Release reported on 09/14/21 that Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual …

Newsheater.com   DA: 14 PA: 50 MOZ Rank: 88

Sarepta Therapeutics Inc New News

  • Sarepta Therapeutics (SRPT) stock price, charts, trades & the US's most popular discussion forums
  • Free forex prices, toplists, indices and lots more

Advfn.com   DA: 13 PA: 30 MOZ Rank: 68

Sarepta (SRPT) falls 0.96% in Light Trading on October 19

  • Today, Sarepta Therapeutics Inc Inc’s (NASDAQ: SRPT) stock fell $0.78, accounting for a 0.96% decrease
  • Sarepta opened at $81.09 before trading between $82.59 and $80.05 throughout

Equities.com   DA: 16 PA: 50 MOZ Rank: 92

Sarepta Therapeutics Announces Proposed $500,000,000

  • Sarepta does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof, except as required by applicable law
  • Source: Sarepta Therapeutics, Inc
  • Investor Contact: Ian Estepan, 617-274-4052 [email protected]
  • Media Contact: Tracy Sorrentino, 617-301-8566

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 23

Recent News for $SRPT Sarepta Therapeutics, Inc

  • Sarepta Therapeutics Announces Initiation of EMBARK, a Global Pivotal Study of SRP-9001, a Gene Therapy for the Treatment of Duchenne Muscular Dystrophy Sep 27 Sarepta Therapeutics, Inc
  • (SRPT) CEO Doug Ingram Presents at Cantor Fitzgerald 2021 Virtual Global Healthcare Conference (Transcript)

Swingtradebot.com   DA: 17 PA: 26 MOZ Rank: 71

$162.77 Million in Sales Expected for Sarepta Therapeutics

  • Equities research analysts expect Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT) to report $162.77 million in sales for the current quarter, Zacks reports
  • Five analysts have provided estimates for Sarepta Therapeutics' earnings
  • The lowest sales estimate is $146.86 million and the highest is …

Marketbeat.com   DA: 18 PA: 50 MOZ Rank: 97

Sarepta Therapeutics, Inc. (SRPT) latest stock news

  • Get the latest Sarepta Therapeutics, Inc
  • (SRPT) stock news and headlines to help you in your trading and investment decisions.

Uk.finance.yahoo.com   DA: 20 PA: 16 MOZ Rank: 66

SRPT: Sarepta Therapeutics Inc

  • Latest On Sarepta Therapeutics Inc
  • Stocks making the biggest moves midday: BlackRock, Moderna, Vimeo and more October 13, 2021CNBC.com
  • What to watch today: Wall Street looks to avoid a four

Cnbc.com   DA: 12 PA: 12 MOZ Rank: 55

Sarepta Therapeutics Inc. [SRPT] is -51.32% lower this YTD

  • [NASDAQ: SRPT] closed the trading session at $83.00 on 10/14/21
  • The day’s price range saw the stock hit a low of $82.27, while the highest price level was $85.75
  • The company report on October 14, 2021 that Sarepta Therapeutics Announces Pricing of …

Dbtnews.com   DA: 11 PA: 50 MOZ Rank: 93

SAREPTA THERAPEUTICS, INC. : SRPT Stock Price

  • is a commercial-stage biopharmaceutical company
  • The Company is focused on the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases
  • It is developing therapeutic candidates for a range of diseases and

Marketscreener.com   DA: 22 PA: 47 MOZ Rank: 17

All News for SRPT : Sarepta Therapeutics, Inc.

  • Sarepta Therapeutics (SRPT) Reports Q1 Loss, Tops Revenue Estimates
  • by Zacks Equity Research Published on May 05,2021
  • Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of -4

Zacks.com   DA: 13 PA: 29 MOZ Rank: 76

Sarepta Therapeutics Inc New News

  • Sarepta Therapeutics Announces Preliminary Financial Results.
  • Sarepta Therapeutics Announces Proposed $500,000,000 Public.
  • Sarepta Therapeutics’ SRP-9001 Shows Sustained Functional.
  • Sarepta Therapeutics Opens Genetic Therapies Center of.
  • Sarepta Therapeutics Announces Initiation of EMBARK, a..

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 97

Sarepta Therapeutics’ SRP-9001 Shows Sustained Functional

  • Sarepta does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof, except as required by law
  • Source: Sarepta Therapeutics, Inc
  • Investor Contact: Ian Estepan, 617-274-4052 [email protected]
  • Media Contact: Tracy Sorrentino, 617-301-8566 [email protected]

Stocktitan.net   DA: 18 PA: 50 MOZ Rank: 14

Sarepta Therapeutics, Inc.

  • Find the latest Sarepta Therapeutics, Inc., SRPT stock market data
  • Get a full understanding of how Sarepta Therapeutics, Inc
  • is performing with stock quotes and prices, as well as real-time news

Thestreet.com   DA: 17 PA: 11 MOZ Rank: 65

Sarepta Therapeutics, Inc.

  • View detailed financial information, real-time news, videos, quotes and analysis on Sarepta Therapeutics, Inc
  • Explore commentary on Sarepta Therapeutics, Inc…

Realmoney.thestreet.com   DA: 23 PA: 16 MOZ Rank: 77

Sorrento Therapeutics Inc. (NASDAQ: SRNE) Receives

  • (NASDAQ: SRNE) had initially announced that its subsidiary Levena (Suzhou) Biopharma Cop
  • Ltd and its partner Escugen Biotechnology Co
  • Ltd had received an authorization letter from the National Medical Products Administration’s Centre for Drug Evaluation for the application for clinical trials of recombinant humanize anti-trop2 Mab-SN38 conjugate (ESG-401).

Biopharmajournal.com   DA: 20 PA: 50 MOZ Rank: 11

Sarepta Therapeutics Inc(SRPT) Stock Price,News,Quote-Moomoo

Provide the latest Sarepta Therapeutics Inc(SRPT) market data, including prices, cycle charts, basic information and real-time news information, financial analysis, company introduction, dividends and dividend information, you can also use Moomoo to open an account to trade Sarepta Therapeutics Inc stocks,we will provide investors with reference decision data.

Moomoo.com   DA: 14 PA: 20 MOZ Rank: 74

Sarepta Therapeutics Inc. (NASDAQ:SRPT) gain 1.02% – Is It

  • (SRPT) saw an uptrend of 1.02% in the recent trading with $92.01 being its most recent
  • The current price level -49.40% lower than the highest price of $181.83 marked by the stock while trading over the past 52-weeks, whereas it is 40.90% higher than the lowest price of $65.30 the company dropped to over past 52-weeks.

Baxterreport.com   DA: 16 PA: 50 MOZ Rank: 9

Sarepta Therapeutics Inc SRPT

  • is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases

Money.usnews.com   DA: 16 PA: 47 MOZ Rank: 8

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Antech-inc.com 134 days lefteNom, LLCRIPE Network Coordination Centre
Niora4x4club.com 345 days leftPDR Ltd. d/b/a PublicDomainRegistry.comYHC Corporation
Alternatesystems.com2 years, 286 days leftNetEarth One Inc. d/b/a NetEarthGoogle LLC
Stmz.net3 years, 18 days leftAlibaba Cloud Computing (Beijing) Co., Ltd.CHINANET jiangsu province network
Profinium.com2 years, 26 days leftTLDS L.L.C. d/b/a SRSPlusCloudflare, Inc.
Supremeq.com2 years, 125 days leftPDR Ltd. d/b/a PublicDomainRegistry.comHandy Networks, LLC
Grandbluesky.com 260 days leftReg2C.com Inc.Cloudflare, Inc.
Donpeterson.com4 years, 195 days leftNetwork Solutions, LLCRackspace Hosting
Gamboool.com1 year, 8 days leftGoDaddy.com, LLCAmazon Technologies Inc.
Grewalguyatt.ca1 year, 21 days leftNameCheap, Inc.Namecheap, Inc.

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]